Stjepan Oreskovic

Stjepan Oreskovic's picture

Stjepan is an entrepreneur and scientist.

 He believes that leadership and coaching capacities are fundamental to sustainable business development.   

In only five years, the M Plus Group, a publicly listed company (MRUL) where Stjepan is a majority shareholder, grew from a boutique BPTO to a leading CX industry player, with over 13.600 employees in 16 countries and working in 62 markets globally. The M+ Group is recognized for its relentless pursuit of excellence and innovation with Frost & Sullivan's 2022 European Entrepreneurial Company of the Year Award. It is a leader in promoting and implementing SDG/ESG sustainability goals. Stjepan was honored in 2023 with the prestigious Nikola Tesla Award for Ethical Business. The award was presented by Transparency International Croatia and the Nikola Tesla Association - Genius for the Future. 

He is also the President of the Supervisory Board of IEDC Bled School of Management and a European Academy of Sciences and Arts member.

In his scientific and educational professional activities, he serves as a tenured professor at the University of Zagreb School of Medicine, where he led joint academic, research, and consultancy projects with the London School of Economics and Political Science, London School of Hygiene and Tropical Medicine, Harvard School of Public Health, Bocconi Univerisity Milan, University of Trieste, and Ljubljana University.

He is the principal investigator for the Global GRAND Project (2018-2023), involving research teams from Harvard Medical School - Massachusetts General Hospital, Ljubljana, and Zagreb School of Medicine.

Stjepan is also the director of the World Health Organization Collaborating Centre for HIV Strategic Information. He founded the Center in 2003, committed to helping countries develop strategic information for a more effective HIV response by providing innovative training and technical assistance. Over 2600 professionals from 110 countries in Europe, Africa, the Americas, the Caribbean, the Middle East, Asia, and Australia have been trained in HIV surveillance, monitoring, and evaluation.

He authored 156 peer-reviewed papers with leading global publishers such as Cambridge University Press, Springer Publishing, Elsevier Science, Wiley-Blackwell, and Pergamon Press (Google Scholar I-10 36 Index). He also consulted for international organizations such as The World Bank, EU Commission, and WHO. 

He is best known for his projects fostering innovative healthcare interventions and research in tobacco control, obesity prevention, and new types of addictions, including internet addiction. His key projects were featured in the Lancet and the BMJ. He was quoted in the leading international media, including Bloomberg, Huffington Post,   Reuters, CNN, BBC, NBC, Associated Press, and RTL.